Researchers have developed a tablet that prevents cancer cells from hiding from the immune system, allowing existing treatments to detect and destroy tumours. In a trial involving patients who had exhausted other options, the drug helped shrink tumours in six common forms of the disease - offering a potential new path for those who do not respond to standard immunotherapy.